Across TCGA pan-cancer cohorts, RNU6ATAC34P RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RNU6ATAC34P’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where RNU6ATAC34P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNU6ATAC34P is over-expressed in tumor, although a few such as KIRC show the opposite, repressed pattern.

HNSC, STAD, and UCEC are the cancer types where RNU6ATAC34P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU6ATAC34P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	All	+0.078	.017	4	view →
STAD	All	II,III,IV	+0.205	.003	3	view →
UCEC	All	All	+0.154	.038	2	view →
KIRC	All	All	−0.027	.048	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: RNU6ATAC34P RNA expression & survival · all RNU6ATAC34P data types